Recent Finacing
Recent Raise
Atreca uses proprietary Immune Repertoire Capture technology to perform high-throughput single-cell antibody and TCR sequencing from patients, discovering antigen-agnostic therapeutic antibodies and TCRs for oncology and infectious diseases.
